Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients

Iranian Journal of Allergy, Asthma and Immunology

Volumn 8, Issue 4, 2009, Pages 193-198

  Mousavi, Tahereh ^a   Poormoghim, Hadi ^a   Moradi, Maziar ^a   Tajik, Nader ^a   Shahsavar, Farhad ^b   Soofi, Mahboobeh ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Khorram Abad University   (Iran)

Author keywords

Ankylosing spondylitis; CD16; CD56; Natural killer cell

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; NATURAL KILLER CELL; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE;

ADULT; ANTIGENS, CD56; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RECEPTORS, IGG; SPONDYLITIS, ANKYLOSING;

EID: 77951581599     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Calin A. Ankylosing spondylitis. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editor. Oxford Textbook of Rheumatology. Vol.2. Oxford: Oxford University Press, 1998; 1058-1070
2. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, Sieper J. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41(1):58-67. (Pubitemid 28041923)
3. Horwitz DA, Gray JD, Ohtsuka K, Hirokawa M, Takahashi T. The immunoregulatory effects of NK cells: the role of TGF-β and implications for autoimmunity. Immunol Today 1997; 18(11):538-542 (Pubitemid 127772687)
4. French AR, Yokoyama WM. Natural killer cells and autoimmunity. Arthritis Res Ther 2004; 6(1):8-14.
5. Flodström-Tullberg M, Bryceson YT, Shi FD, Höglund P, Ljunggren HG. Natural killer cells in human autoimmunity. Curr Opin Immunol 2009; 21(6):634-640
6. Flodstrom M, Shi FD, Sarvetnick N, Ljunggren HG. The natural killer cell-friend or foe in autoimmune disease? Scand J Immunol 2002; 55(5):432-441
7. Díaz-Peña R, Blanco-Gelaz MA, López-Larrea C. KIR genes and their role in spondyloarthropathies. Adv Exp Med Biol 2009; 649:286-299
8. Olivieri I, D'Angelo S, Scarano E, Santospirito V, Padula A. The HLA-B*2709 subtype in a woman with early ankylosing spondylitis. Arthritis Rheum 2007; 56(8):2805-2807 (Pubitemid 47237303)
9. Cauli, Vacca A, Mameli A, Passiu G, Fiorillo M.T. Sorrentino R, Mathieu A. A Sardinian patient with ankylosing spondylitis and HLA-B*2709 co-occurring with HLA-B*1403. Arthritis Rheum 2007; 56(8):2807-2809 (Pubitemid 47237304)
10. Díaz-Peña R, Blanco-Gelaz MA, Njobvu P, López-Vazquez A, Suárez-Alvarez B, López-Larrea C. Influence of HLA-B*5703 and HLA-B*1403 on susceptibility to spondyloarthropathies in the Zambian population. Journal of heumatology 2008; 35(11):2236-2240
11. Cascino I, Paladini F, Belfiore F, Cauli A, Angelini C, Fiorillo MT, Mathieu A, Sorrentino R. Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia. Arthritis Rheum 2007;56(8):2640-2651 (Pubitemid 47237282)
12. Jiao YL, Ma CY, Wang LC, Cui B, Zhang J, You L, Chen ZJ, Li JF, Zhao YR.. Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease. J Clin Immunol 2008; 28(4):343-349
13. Reyes AA, Small SJ, Akeson R. At least 27 alternatively spliced forms of the neural cell adhesion molecule mRNA are expressed during rat heart development. Mol Cell Biol 1991; 11(3):1654-1661 (Pubitemid 21895524)
14. Janeway C.A, Travers P, Walport M, Shlomchik M. Immunobiology. New York. Garland Publishing 2001;254.
15. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22(11):633-640
16. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27(4):361-368
17. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21(12):2281-2285
18. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21(12):2286-2291
19. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008;9(5):503-510.
20. Caligiuri MA: Human natural killer cells. Blood 2008;112(3):461-469
21. Zhang AL, Colmenero P, Purath U, Teixeira de Matos C, Hueber W, Klareskog L, et al. Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood 2007; 110(7):2484-2493 (Pubitemid 47523170)
22. Dalbeth N, Gundle R, Davies RJ, Lee YC, McMichael AJ, Callan MF: CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol 2004;173(10):6418- 6426 (Pubitemid 39487802)
23. Shi FD, Ljunggren HG, Sarvetnick N. Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol 2001; 22(2):97-101. (Pubitemid 32667529)
24. Shi FD, van Kaer L. Reciprocal regulation between natural killer cells and autoreactive T cells. Nat Rev Immunol 2006; 6(10):751-760 (Pubitemid 44453461)
25. Shamji MF, Bafaquh M, Tsai E. The pathogenesis of ankylosing spondylitis. Neurosurg Focus 2008; 24(1):E3.
26. Szántó S, Aleksza M, Mihály E, Lakos G, Szabó Z, Végvári A, et al. Intracytoplasmic cytokine expression and T cell subset distribution in the peripheral blood of patients with ankylosing spondylitis. J Rheumatol 2008;35(12):2372-2375
27. Park YW, Kee SJ, Cho YN, Lee EH, Lee HY, Kim EM, et al. Impaired Differentiation and Cytotoxicity of Natural Killer Cells in Systemic Lupus Erythematosus. Arthritis Rheum 2009; 60(6):1753-1763
28. Green MR, Kennell AS, Larche MJ, Seifert MH, Isenberg DA, Salaman MR. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients. Clin Exp Immunol 2005; 141(1):165-173
29. Azuz-Lieberman N, Markel G, Mizrahi S, Gazit R, Hanna J, Achdout H, et al. The involvement of NK cells in ankylosing spondylitis. Int Immunol 2005; 17(7):837-845
30. Dalbeth N, Callan MF. A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum 2002; 46(7):1763-1796
31. Lima M, Teixeira MA, Queirós ML, Leite M, Santos AH, Justiça B, et al. Immunophenotypic characterization of normal blood CD56 + lo versus CD56+hi Nk cell subsets and its impact on the understanding of their tissue distribution and functional properties. Blood Cell Mole. Disea 2001; 27(4):731-743 (Pubitemid 33022301)